SalesTrax.com Research: Pfizer, Inc.

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.


Pharmaceutical Business Review

2009-08-27 16:03
Pfizer Signs Co-promotion Agreement For Caduet Combination Tablets With Astellas
Pfizer, responsible for manufacturing and sales of the tablets

2009-07-31 08:03
Pfizer, Medivation Initiate Phase 3 Trial Of Dimebon
Entitled to a seven-year period of marketing exclusivity in the US

2009-06-02 04:03
Pfizer, Celldex Provides Update On Brain Cancer Studies
Pfizer and Celldex Therapeutics has announced the updated data from two clinical trials of CDX-110 in newly-diagnosed glioblastoma multiforme (GBM) at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO). CDX-110, an investigational immunotherapeutic vaccine that targets the tumor-specific molecule, epidermal growth factor receptor variant III (EGFRvIII).